Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Stryker ( (SYK) ) has provided an announcement.
Stryker disclosed that a cybersecurity incident identified and reported to the U.S. SEC on March 11 and 12, 2026 disrupted its corporate network, including its Microsoft environment, but current findings indicate no malicious activity directed at customers, suppliers, vendors, or partners. Working with Palo Alto Networks’ Unit 42, Stryker has contained the breach, eradicated known indicators of compromise, isolated or rebuilt affected systems, and is still assessing whether the event will have a material operational or financial impact.
A March 20, 2026 assurance letter from Unit 42 states there is no evidence of ongoing unauthorized access in Stryker’s environment and that the immediate risk to operations has been mitigated, while the company continues updates to stakeholders via its website. The investigation remains ongoing, with Stryker and third-party experts, including Microsoft, focused on recovering identity infrastructure and validating security measures as they evaluate potential reputational, regulatory, and financial consequences.
The most recent analyst rating on (SYK) stock is a Buy with a $450.00 price target. To see the full list of analyst forecasts on Stryker stock, see the SYK Stock Forecast page.
Spark’s Take on SYK Stock
According to Spark, TipRanks’ AI Analyst, SYK is a Neutral.
SYK scores well on core fundamentals and management’s constructive 2026 outlook, but the overall score is held back by weak current technical momentum, a premium valuation (high P/E, modest yield), and added near-term uncertainty from the cybersecurity-related operational disruption.
To see Spark’s full report on SYK stock, click here.
More about Stryker
Stryker Corporation is a global medical technology company that develops and manufactures a wide range of products for orthopaedics, neurotechnology, and surgical and medical devices. The company serves hospitals, healthcare providers, and related partners worldwide, focusing on advanced clinical solutions and supporting critical healthcare infrastructure and procedures.
Average Trading Volume: 2,011,473
Technical Sentiment Signal: Hold
Current Market Cap: $128.5B
For an in-depth examination of SYK stock, go to TipRanks’ Overview page.